BioForm Medical (BFRM) Reports Q4 Loss of $0.43; Guides FY09 Sales
More News related to BFRM
- Piper Jaffray Upgrades BioForm Medical (BFRM) to Overweight; Worst of Aesthetic Storm Have Passed
- BioForm Medical Reports Financial Results for Quarter Ended September 30, 2009, First Quarter of Fiscal 2010
- Bioform Medical Announces Earnings Call on November 2, 2009, and Presentation at Upcoming Investor Conference
- BioForm Medical to Present At the Maxim Group Growth Conference
- Piper Jaffray Upgrades BioForm Medical (BFRM) to Neutral; Holding Their Own Against Larger Players
More News related to Earnings
- Hertz Global (HTZ) Appoints Scott P. Sider as President of the Americas
- Noah Education Holdings (NED) Appoints Tang to President and COO and Jerry He to EVP and CFO
- Western Union (WU) Promotes Hikmet Ersek to COO
- Bruker Corp. (BRKR) Appoints Knight to COO and Monahan to CFO
- Rimage Corp (RIMG) To Promote Sherman Black to CEO and Board Member
BioForm Medical, Inc. (Nasdaq: BFRM) reports a Q4 loss of $0.43, versus the analyst estimate of a loss of $0.16 and compared to a loss of $1.20 in the same quarter last year. Revenues for the quarter were $16.7 million, versus the consensus of $15.90 million.
Sees FY09 sales in the range of $74-$78 million, versus the consensus of $74.25 million.
BioForm Medical, Inc., a medical aesthetics company, focuses on developing and commercializing products that are used by physicians to enhance a patient's appearance.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
